MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    The Magnetic Resonance Parkinsonism Index as a diagnostic marker for differentiating PSP from IPD

    L. Haupt, S. Kannenberg, J. Caspers, C. Hartmann, A. Schnitzler (Düsseldorf, Germany)

    Objective: The Magnetic Resonance Parkinsonism Index (MRPI) has been proposed as an enhancement of the Midbrain to Pons Ratio (MTPR) as a diagnostic tool for…
  • 2022 International Congress

    Efficacy of Apomorphine Sublingual Film Versus Subcutaneous Apomorphine for the Treatment of OFF Episodes in Parkinson’s Disease

    F. Stocchi, O. Rascol, W. Poewe, R. Chaudhuri, J. Kassubek, L. Lopez Manzanares, V. Leta, I. Zhang, A. Bowling, S. Wu, E. Pappert (Rome, Italy)

    Objective: Evaluate efficacy and patient satisfaction associated with apomorphine sublingual film (SL-APO) vs subcutaneous apomorphine (SC-APO) for the treatment of OFF episodes in patients with…
  • 2022 International Congress

    Influence of alcohol consumption on cognitive decline in Parkinson disease.

    E. Ruiz-Fernández, J. Marín-Lahoz, J. Pagonabarraga, A. Horta-Barba, S. Martínez-Horta, H. Bejr-Kasem, I. Aracil-Bolaños, A. Campolongo, J. Kulisevsky (Zaragoza, Spain)

    Objective: To assess whether alcohol consumption (AC) is independently associated with cognitive decline (CD) in PD. Background: AC is linked to dementia and neurological damage…
  • 2022 International Congress

    Comparing duodenal levodopa infusion based on length of treatment in advanced Parkinson’s.

    J. Alonso Maroto, E. Casas Peña, I. Muro García, M. Domínguez Gallego, E. Valiente Gordillo, L. López Manzanares, JA. Vivancos Mora (Madrid, Spain)

    Objective: In this study we seek to compare characteristics and complications of patients suffering from advanced Parkinson's treated with duodenal levodopa infusion. Background: Motor fluctuations…
  • 2022 International Congress

    Resting heart rate variability in Parkinson’s disease with and without freezing of gait

    M. Falla, M. Masé, A. Randi, G. Strapazzon (Rovereto

    Objective: The aim of the study was to investigate heart rate variability (HRV) in Parkinson’s disease (PD) patients with and without freezing of gait (FOG). Background: FOG and…
  • 2022 International Congress

    Measuring functional cognition with the Short Weekly Calendar Planning Activity in patients with Parkinson’s disease and non-manifesting LRRK2 and GBA carriers

    T. Schejter Margalit, N. Ben Binyamin, A. Thaler, I. Maidan, J. Cederbaum, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, N. Giladi, A. Mirelman, R. Kizony (Tel Aviv, Israel)

    Objective: The aims of this study were to explore the feasibility of the short Weekly Calendar Planning Activity (WCPA-10) to investigate functional cognition in patients…
  • 2022 International Congress

    Patient-Specific Outcomes of Transcutaneous Afferent Patterned Stimulation with Varying Frequencies for Essential Tremor and Parkinson’s Disease

    A. Kent, H. Kim, D. Khosla, K. Rosenbluth (Foster City, USA)

    Objective: Two studies were conducted to compare the safety, effectiveness, and comfort of fixed- and variable-frequency transcutaneous afferent patterned stimulation (TAPS) for action tremor relief…
  • 2022 International Congress

    The mGlu2 positive allosteric modulator BINA extends enhances low dose L-DOPA anti-parkinsonian action in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine the effect of positive allosteric modulation of the metabotropic glutamate type 2 (mGlu2) receptor in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset using a low…
  • 2022 International Congress

    Mapping of the International Classification of Functioning, Disability and Health categories in the Pre-Assessment Information Form for People with Parkinson’s Disease.

    F. Rogatto, E. Guelfi, G. Pereira, S. Silva (São Paulo, Brazil)

    Objective: Perform the linkage between the items of the Pre-Assessment Information Form (PAIF) of the people with Parkinson's Disease (pPD) with the categories of the…
  • 2022 International Congress

    Microglial activation facilitates alpha synuclein propagation and neurodegeneration in αSyn preformed fibrils (PFF)-injected PD mouse model

    YE. Kim, TT. Lai, F. Richter, HI. Ma (Anyang, Republic of Korea)

    Objective: To evaluate whether microglial activation aggravates synucleinopathy progression in Parkinson's disease (PD) mouse model. Background: Alpha-synuclein (αSyn) accumulation underlay the main pathological process of…
  • « Previous Page
  • 1
  • …
  • 433
  • 434
  • 435
  • 436
  • 437
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley